Researcher Warns Lack of Raw Data Sharing Is Making Proteomics Vulnerable to Fraud | GenomeWeb

According to one proteomics researcher, a lack of requirements around the deposition of raw mass spec data has left the field vulnerable to shoddy work and fraudulent results.

Ben Orsburn, senior applications scientist at Thermo Fisher Scientific, told ProteoMonitor this week that proteomics' increasingly large datasets and sophisticated statistical techniques have created opportunities for researchers to push questionable findings into print, a problem that he said has touched even some of the field's top journals.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Cell this week: phosphoproteomic patterns in prostate cancer, effect of gene expression on fitness in yeast, and more.

Scripps Research Institute investigators peer back at the RNA world.

Being born premature shouldn't mean infants with high blood sugar levels don't undergo genetic testing for neonatal diabetes, a study in Pediatrics says.

An op-ed in the Wall Street Journal calls for the establishment of a patent court staffed by judges and experts with science backgrounds.